These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37203243)

  • 1. Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.
    Bouisset F; Sia J; Mizukami T; Karjalainen PP; Tonino PAL; Pijls NHJ; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Lalmand J; Frambach P; Roza da Costa B; Collet C; De Bruyne B;
    JAMA Cardiol; 2023 Jul; 8(7):703-708. PubMed ID: 37203243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
    Tonino PAL; Pijls NHJ; Collet C; Nammas W; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Sia J; Lalmand J; Frambach P; Penaranda AS; De Bruyne B; Karjalainen PP;
    JACC Cardiovasc Interv; 2020 Jul; 13(14):1697-1705. PubMed ID: 32703593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.
    Planer D; Smits PC; Kereiakes DJ; Kedhi E; Fahy M; Xu K; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1104-15. PubMed ID: 22017936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
    Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
    Karjalainen PP; Nammas W; Ylitalo A; de Bruyne B; Lalmand J; de Belder A; Rivero-Crespo F; Kervinen K; Airaksinen JKE
    Int J Cardiol; 2016 Nov; 222():275-280. PubMed ID: 27497110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
    Nammas W; de Belder A; Niemelä M; Sia J; Romppanen H; Laine M; Karjalainen PP
    Eur J Intern Med; 2017 Jan; 37():43-48. PubMed ID: 27499178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes.
    Sia J; Nammas W; Collet C; De Bruyne B; Karjalainen PP
    Rev Esp Cardiol (Engl Ed); 2023 Mar; 76(3):150-156. PubMed ID: 35752571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
    Karjalainen PP; Airaksinen JK; de Belder A; Romppanen H; Kervinen K; Sia J; Laine M; Nammas W
    Ann Med; 2016 Aug; 48(5):376-83. PubMed ID: 27238465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction.
    Brugaletta S; Gomez-Lara J; Ortega-Paz L; Jimenez-Diaz V; Jimenez M; Jiménez-Quevedo P; Diletti R; Mainar V; Campo G; Silvestro A; Maristany J; Flores X; Oyarzabal L; De Miguel-Castro A; Iñiguez A; Serra A; Nombela-Franco L; Ielasi A; Tespili M; Lenzen M; Gonzalo N; Bordes P; Tebaldi M; Biscaglia S; Rodriguez-Arias JJ; Al-Shaibani S; Arevalos V; Romaguera R; Gomez-Hospital JA; Serruys PW; Sabaté M
    J Am Coll Cardiol; 2021 Mar; 77(9):1165-1178. PubMed ID: 33663733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
    Zbinden R; Piccolo R; Heg D; Roffi M; Kurz DJ; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Franzone A; Eberli F; Jüni P; Windecker S; Pilgrim T
    J Am Heart Assoc; 2016 Mar; 5(3):e003255. PubMed ID: 26979080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.
    Nammas W; Airaksinen JKE; Romppanen H; Sia J; de Belder A; Karjalainen PP
    Angiology; 2017 Jul; 68(6):513-518. PubMed ID: 27543565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.
    Karjalainen P; Kiviniemi TO; Lehtinen T; Nammas W; Ylitalo A; Saraste A; Mikkelsson J; Pietila M; Biancari F; Airaksinen JK
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1693-703. PubMed ID: 23996244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
    Karjalainen PP; Niemelä M; Laine M; Airaksinen JK; Ylitalo A; Nammas W
    Am J Cardiol; 2017 Feb; 119(3):345-350. PubMed ID: 27887689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
    JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; Otaegui I; Masotti M; Zueco J; Veláquez M; Sanchís J; García-Touchard A; Lázaro-García R; Moreu J; Bethencourt A; Cuesta J; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C;
    JACC Cardiovasc Interv; 2016 Jun; 9(12):1246-1255. PubMed ID: 27339840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.